Drug Trial Radar · NCT05206370
A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers
Last checked: Nov 20, 2026Latest source record: Jan 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
792
Actual
Start
Jan 20, 2022
Primary completion
Mar 21, 2023
Study completion Mar 21, 2023
Sponsor
- Lead sponsor
- Achieve Life SciencesIndustry
- Sponsor type
- Industry
- First posted
- Jan 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This placebo-controlled Phase 3 study is being conducted at sites within the United States to evaluate 3 mg cytisinicline TID for treatment duration of 42 days/6 weeks and evaluate 3 mg cytisinicline TID for treatment duration of 84 days/12 weeks.
Conditions
- Smoking Cessation
Interventions
CytisiniclineDrug
film-coated oral tablets containing 3 mg cytisinicline
PlaceboDrug
film-coated oral tablets containing matched placebo
Behavioral supportBehavioral
Behavioral support sessions by a qualified study site staff member will be participant-driven and will include direct engagement with the subject about their attempt to quit smoking. Each session will last approximately 10 minutes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Smoking Abstinence From Weeks 3 to Week 6Time frame: Weeks 3 to 6
- Percentage of Participants With Smoking Abstinence From Weeks 9 to Week 12Time frame: Weeks 9 to 12
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Accel Research Sites - DeLand Clinical Research Unit
DeLand, Florida
Alliance for Multispecialty Research, LLC
Fort Myers, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Affinity Health Corp
Oak Brook, Illinois
MediSphere Medical Research Center, LLC
Evansville, Indiana
Global Medical Institutes LLC; Princeton Medical Institute
Princeton, New Jersey
Trial Management Associates, LLC
Wilmington, North Carolina
Velocity Clinical Research, Inc.
Cleveland, Ohio
Aventiv Research Inc
Columbus, Ohio
Intend Research
Norman, Oklahoma
Clinical Research Associates, Inc.
Nashville, Tennessee
Health Research of Hampton Toads, Inc
Newport News, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.